These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4125073)

  • 21. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
    Shimizu T
    Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 23. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 24. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
    Tsukamura M
    Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
    GROSSET J; CANETTI G
    Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
    [No Abstract]   [Full Text] [Related]  

  • 29. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 31. Some experimental aspects of cross-resistance between capreomycin and viomycin.
    Algeorge G; Petre A
    Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892
    [No Abstract]   [Full Text] [Related]  

  • 32. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin, and viomycin. 2. In vitro study of cross resistance to capreomycin, kanamycin and viomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):44-51. PubMed ID: 5401219
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug sensitivity of the so-called atypical mycobacteria].
    Lucchesi M; Mancini P; Matzeu M
    Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis.
    Collins FM; Mackaness GB; Montalbine V; Smith MM
    Am Rev Respir Dis; 1968 Aug; 98(2):189-200. PubMed ID: 4174476
    [No Abstract]   [Full Text] [Related]  

  • 36. Some correlations between chemical structure and mode of action of tuberculostatica. Researches on capreomycin and isoxyl.
    Păunescu E; Stoinescu M; Zaharescu C; Drăguşanu E
    Antibiot Chemother; 1970; 16():10-6. PubMed ID: 4108883
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin and viomycin. 1. In vitro effects of capreomycin on Mycobacterium and the survival of tuberculous mice treated with capreomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):36-43. PubMed ID: 5401218
    [No Abstract]   [Full Text] [Related]  

  • 40. [Paper disk methods for determination of the drug sensitivity of Mycobacterium tuberculosis to the 2d order preparations. II].
    Afanas'eva IuP; Dorozhkova IR
    Lab Delo; 1969; 5():296-8. PubMed ID: 4185263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.